173 related articles for article (PubMed ID: 30001714)
1. A pilot study to profile salivary angiogenic factors to detect head and neck cancers.
van der Merwe L; Wan Y; Cheong HJ; Perry C; Punyadeera C
BMC Cancer; 2018 Jul; 18(1):734. PubMed ID: 30001714
[TBL] [Abstract][Full Text] [Related]
2. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
3. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
[TBL] [Abstract][Full Text] [Related]
4. Tissue expression, serum and salivary levels of vascular endothelial growth factor in patients with HNSCC.
Andisheh-Tadbir A; Hamzavi M; Rezvani G; Ashraf MJ; Fattahi MJ; Khademi B; Kamali F
Braz J Otorhinolaryngol; 2014; 80(6):503-7. PubMed ID: 25457070
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
Kang JW; Eun YG; Lee YC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
[TBL] [Abstract][Full Text] [Related]
6. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
Cai M; Zheng Z; Bai Z; Ouyang K; Wu Q; Xu S; Huang L; Jiang Y; Wang L; Gao J; Pathak JL; Wu L
BMC Cancer; 2022 May; 22(1):530. PubMed ID: 35545767
[TBL] [Abstract][Full Text] [Related]
8. HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.
Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.
Hasina R; Whipple ME; Martin LE; Kuo WP; Ohno-Machado L; Lingen MW
Lab Invest; 2008 Apr; 88(4):342-53. PubMed ID: 18283272
[TBL] [Abstract][Full Text] [Related]
10. Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia.
Martinez-Fierro ML; Castruita-De La Rosa C; Garza-Veloz I; Cardiel-Hernandez RM; Espinoza-Juarez MA; Delgado-Enciso I; Castañeda-Lopez ME; Cardenas-Vargas E; Trejo-Vázquez F; Sotelo-Ham EI; Castañeda-Miranda R; Cid-Baez MA; Ortiz-Rodriguez JM; Solis-Sanchez LO; Aviles AG; Ortiz-Castro Y
Hypertens Pregnancy; 2018 Feb; 37(1):37-50. PubMed ID: 29308696
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.
Lallemant B; Evrard A; Combescure C; Chapuis H; Chambon G; Raynal C; Reynaud C; Sabra O; Joubert D; Hollande F; Lallemant JG; Lumbroso S; Brouillet JP
BMC Cancer; 2009 Oct; 9():370. PubMed ID: 19835631
[TBL] [Abstract][Full Text] [Related]
14. HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated.
Sardari Y; Pardis S; Tadbir AA; Ashraf MJ; Fattahi MJ; Ebrahimi H; Purshahidi S; Khademi B; Hamzavi M
Asian Pac J Cancer Prev; 2012; 13(6):2891-6. PubMed ID: 22938479
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.
Druzgal CH; Chen Z; Yeh NT; Thomas GR; Ondrey FG; Duffey DC; Vilela RJ; Ende K; McCullagh L; Rudy SF; Muir C; Herscher LL; Morris JC; Albert PS; Van Waes C
Head Neck; 2005 Sep; 27(9):771-84. PubMed ID: 15920746
[TBL] [Abstract][Full Text] [Related]
16. Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.
Kim SG; Veena MS; Basak SK; Han E; Tajima T; Gjertson DW; Starr J; Eidelman O; Pollard HB; Srivastava M; Srivatsan ES; Wang MB
Clin Cancer Res; 2011 Sep; 17(18):5953-61. PubMed ID: 21821700
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis.
Wang J; Sun Z; Wang J; Tian Q; Huang R; Wang H; Wang X; Han F
Cancer Med; 2021 Sep; 10(18):6515-6533. PubMed ID: 34331382
[TBL] [Abstract][Full Text] [Related]
18. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma.
Hoefling NL; McHugh JB; Light E; Kumar B; Walline H; Prince M; Bradford C; Carey TE; Mukherji SK
AJNR Am J Neuroradiol; 2013 May; 34(5):1062-6, S1-2. PubMed ID: 23370473
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.
Le Louedec F; Alix-Panabières C; Lafont T; Allal BC; Garrel R; Digue L; Guigay J; Cupissol D; Delord JP; Lallemant B; Alfonsi M; Aubry K; Mazel M; Becher F; Perriard F; Chatelut E; Thomas F
Br J Clin Pharmacol; 2019 Jun; 85(6):1357-1366. PubMed ID: 30811063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
